NRL972 (IN-X)

A single-centre, open, controlled, randomised cross-over study in healthy male and female volunteers to evaluate the pharmacokinetics of cholyl-lysyl-fluorescein (NRL972) in the presence of medication-induced changes in cytochrome P450 or biliary transporter proteins.